Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17658393 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Combined Renin Inhibition/Beta-blockade
Condition: Hypertension
Interventions: Drug: Aliskiren;   Drug: Extended-release metoprolol
2 Completed Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure
Condition: Hypertension
Intervention: Drug: aliskiren

Indicates status has not been verified in more than two years